Role of endotoxaemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 2, 1996, Pages 152-158

  Lee, Fa Yauh ^a,b   Wang, Sun Sang ^a,b   Yang, May Chuen May ^a,b   Tsai, Yang Te ^a,b   Wu, Shwu Ling ^a,b   Lu, Rei Hwa ^a,b   Chan, Cho You ^a,b   Lee, Shou Dong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Endotoxaemia; Endotoxin; Portal hypertension

Indexed keywords

ENDOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTOXEMIA; LIVER CIRCULATION; LIVER CIRRHOSIS; MALE; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT;

EID: 0029897673     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00053.x     Document Type: Article

References (35)

1. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension. Am. J. Physiol. 1983; 244: G52-7.
2. Schrier RW, Caramelo C. Haemodynamic and hormonal alterations in hepatic cirrhosis. In: Epstein M, ed. The Kidney in Liver Disease. Baltimore: Williams and Wilkins, 1988; 265-85.
3. Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats. Hepatology 1992; 15: 323-8.
4. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992; 102: 931-5.
5. ω-nitro-L-arginine ameliorates portal-systemic shunting in portal hypertensive rats. Gastroenterology 1993; 105: 1464-70.
6. ω-Nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993; 17: 84-90.
7. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 1990; 259: H1038-43.
8. Rees DD, Cellek S, Palmer RMJ, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem. Biophys. Res. Commun. 1990; 173: 541-7.
9. Metha R, Gottstein J, Zeller WP, Lichtenberg R, Blei AT. Endotoxin and the hyperdynamic circulation of portal vein-ligated rats. Hepatology 1990; 12: 1152-6.
10. Blei AT, Gottstein J, Ganger D. Oral neomycin normalizes haemodynamic features of awake, portal hypertensive rats. Hepatology 1988; 8: 1253 (Abstract).
11. Genecin P, Colombato LA, Ferraioli G, Groszmann RJ. Neomycin reduces ammonia levels without ameliorating the hyperdynamic circulation in two portal hypertensive rat models. Hepatology 1989; 10: 586 (Abstract).
12. Ruiter DJ, Van der Meulen J, Brouwer A et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab. Invest. 1981; 45: 38-45.
13. Munford RS, Hall CL. Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice. Infect. Immun. 1985; 48: 464-73.
14. Fukuda I, Tanamoto K, Kanegasaki S, Yajima Y, Goto Y. Deacylation of bacterial lipopolysaccharide in rat hepatocytes in vitro. Br. J. Exp. Pathol. 1989; 70: 267-74.
15. Liehr H. Endotoxins and pathogenesis of hepatic and gastrointestinal diseases. Adv. Intern. Med. Pediatr. 1982; 48: 117-93.
16. Prytz H, Bjørneboe M, Johansen TS, Ørskov F. The influence of portosystemic shunt operation of immunoglobulins and Escherichia coli antibodies in patients with cirrhosis of the liver. Acta Med. Scand. 1974; 196: 109-12.
17. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am. J. Physiol. 1985; 248: G618-25.
18. Lin HC, Soubrane O, Lebrec D. Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats. Hepatology 1991; 14: 325-30.
19. Blei AT, O'Reilly DJ, Gottstein J. Portal-systemic shunting and the haemodynamic effect of nitroglycerin in the rat. Gastroenterology 1984; 86: 1428-36.
20. Pizcueta P, Piqué JM, Fernández M et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-15.
21. Colombato LA, Albillos A, Genecin P, Sarin S, Groszmann RJ. Prevention of portal-systemic shunting in propranolol-treated and in sodium-restricted cirrhotic rats. Gastroenterology 1991; 100: 730 (Abstract).
22. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984; 87: 1120-6.
23. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am. J. Physiol. 1981; 240: G371-5.
24. Chiang JH, Cheng HC, Yang MCM et al. Lung deposit of lipiodol in normal and cirrhotic rats. Acta Radiol. 1991; 32: 474-8.
25. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988; 8: 232-6.
26. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: Re-evaluation with an improved chromogenic assay. J. Hepatol. 1991; 12: 162-9.
27. Fukui H, Brauner B, Bode JC, Bode C. Chromogenic endotoxin assay in plasma selection of plasma pretreatment and production of standard curves. J. Clin. Chem. Clin. Biochem. 1989; 27: 941-6.
28. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 1991; 337: 776-8.
29. Michielsen PP, Ramon AM, Van Assche KJ, Pelckmans PA, Van Maercke YM. Endotoxaemia in portal hypertensive rats. Hepatology 1993; 18: 284 (Abstract).
30. Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon DN, Traber DL. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxaemia. Crit. Care. Med. 1994; 22: 306-12.
31. Pernow J. Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: Involvement of the endothelium. Br. J. Pharmacol. 1989; 97: 983-7.
32. Curry FE. Modulation of venular microvessel permeability by calcium influx into endothelial cells. FASEB 1992; 6: 2456-66.
33. Dubuisson L, Bioulac-Sage P, Bedin C, Balabaud C. Sinusoidal cells in rats with portacaval shunt: A morphometric study. J. Submicrosc. Cytol. Pathol. 1982; 14: 453-60.
34. Bigatello LM, Broitman SA, Fattori L et al. Endotoxaemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 1987; 82: 11-15.
35. Iwanaga S, Morita T, Harada T et al. Chromogenic substrates for horseshoe crab clotting enzyme, its application for the assay of bacterial endotoxin. Haemostasis 1978; 7: 183-8.